ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion 登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。
Bicara Therapeutics Inc

Bicara Therapeutics Inc (BCAX)

14.88
1.21
(8.85%)
終了 3月6日 6:00AM
14.88
0.00
(0.00%)
取引時間後: 7:36AM
高度なチャート

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

主要統計と詳細

通貨
14.88
買値
13.06
売値
14.88
出来高
343,386
12.81 日の範囲 14.93
11.10 52 週間の範囲 28.09
時価総額
前日終値
13.67
始値
13.146
最終取引時間
財務取引量
US$ 4,849,045
VWAP
14.1213
平均取引量 (3 か月)
449,472
発行済株式数
54,415,619
配当利回り
-
PER
-15.58
1 株当たり利益 (EPS)
-0.96
歳入
-
純利益
-51.99M

Bicara Therapeutics Inc について

Bicara Therapeutics is a clinical-stage biopharmaceutical company committed to bringing transformative bifunctional therapies to patients with solid tumors. Our lead program ficerafusp alfa is a bifunctional antibody that combines two clinically validated targets, an epidermal growth factor receptor... Bicara Therapeutics is a clinical-stage biopharmaceutical company committed to bringing transformative bifunctional therapies to patients with solid tumors. Our lead program ficerafusp alfa is a bifunctional antibody that combines two clinically validated targets, an epidermal growth factor receptor, or EGFR, directed monoclonal antibody with a domain that binds to human transforming growth factor beta, or TGF-b. Ficerafusp alfa is initially being developed in head and neck squamous cell carcinoma, or HNSCC, where there remains a significant unmet need. We intend to initiate a pivotal Phase 2/3 trial of ficerafusp alfa in combination with pembrolizumab as a first-line therapy in recurrent/metastatic HNSCC excluding HPV-positive patients with oropharyngeal squamous cell carcinoma late in the fourth quarter of 2024 or early in the first quarter of 2025. 詳細を表示

セクター
Pharmaceutical Preparations
業界
Pharmaceutical Preparations
ウェブサイト
本社
Wilmington, Delaware, USA
設立
-
Bicara Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the ナスダック市場 with ticker BCAX. The last closing price for Bicara Therapeutics was US$13.67. Over the last year, Bicara Therapeutics shares have traded in a share price range of US$ 11.10 to US$ 28.09.

Bicara Therapeutics currently has 54,415,619 shares in issue. The market capitalisation of Bicara Therapeutics is US$743.86 million. Bicara Therapeutics has a price to earnings ratio (PE ratio) of -15.58.

BCAX 最新ニュース

期間 †前日比前日比 %始値高値安値平均出来高VWAP
12.5720.877335499612.3114.8811.76527153312.93969784CS
42.5620.779220779212.3214.8811.6433540112.92396513CS
12-4.64-23.770491803319.5220.708711.144947214.95199043CS
26-11.37-43.314285714326.2528.0911.140998518.48901397CS
52-11.37-43.314285714326.2528.0911.140998518.48901397CS
156-11.37-43.314285714326.2528.0911.140998518.48901397CS
260-11.37-43.314285714326.2528.0911.140998518.48901397CS

BCAX - Frequently Asked Questions (FAQ)

What is the current Bicara Therapeutics share price?
The current share price of Bicara Therapeutics is US$ 14.88
How many Bicara Therapeutics shares are in issue?
Bicara Therapeutics has 54,415,619 shares in issue
What is the market cap of Bicara Therapeutics?
The market capitalisation of Bicara Therapeutics is USD 743.86M
What is the 1 year trading range for Bicara Therapeutics share price?
Bicara Therapeutics has traded in the range of US$ 11.10 to US$ 28.09 during the past year
What is the PE ratio of Bicara Therapeutics?
The price to earnings ratio of Bicara Therapeutics is -15.58
What is the reporting currency for Bicara Therapeutics?
Bicara Therapeutics reports financial results in USD
What is the latest annual profit for Bicara Therapeutics?
The latest annual profit of Bicara Therapeutics is USD -51.99M
What is the registered address of Bicara Therapeutics?
The registered address for Bicara Therapeutics is CORPORATION TRUST CENTER, 1209 ORANGE ST, NEW CASTLE, WILMINGTON, DELAWARE, 19801
What is the Bicara Therapeutics website address?
The website address for Bicara Therapeutics is www.bicara.com
Which industry sector does Bicara Therapeutics operate in?
Bicara Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector

ムーバー

すべて表示
  • 出来高
  • 値上がり率
  • 値下がり率
銘柄コード株価出来高
GVVisionary Holdings Inc
US$ 3.6999
(186.81%)
188.04M
CMRXChimerix Inc
US$ 8.435
(70.06%)
118.56M
ARBBARB IOT Group Ltd
US$ 0.8262
(58.88%)
87.92M
CDXCChromaDex Corporation
US$ 8.5507
(52.69%)
18.71M
SOBRSOBR Safe Inc
US$ 0.6602
(41.04%)
10.67M
CUTRCutera Inc
US$ 0.1209
(-61.55%)
23.22M
XCURExicure Inc
US$ 9.92
(-30.53%)
133.38k
STBXStarBox Group Holdings Ltd
US$ 0.3481
(-29.20%)
2.7M
LBGJLi Bang International Corporation Inc
US$ 1.50
(-25.00%)
269.2k
SMSTDefiance Daily Target 2x Short MSTR ETF
US$ 4.7255
(-24.75%)
29.42M
NVDANVIDIA Corporation
US$ 117.30
(1.13%)
284.33M
GVVisionary Holdings Inc
US$ 3.6999
(186.81%)
188.04M
ADTXAditxt Inc
US$ 0.0592
(18.88%)
160.54M
INTCIntel Corporation
US$ 20.81
(-2.44%)
127.21M
CMRXChimerix Inc
US$ 8.435
(70.06%)
118.56M

BCAX 財務

財務

最近閲覧した銘柄

Delayed Upgrade Clock